Skip to content

Cannabis: all studies

Page 76 of 294: studies 751 to 760 of 2,937, newest first. Back to the cannabis overview

Research

Resting state functional connectivity in the default mode network: Relationships between cannabis use, gender, and cognition in adolescents and young adults

NeuroImage: Clinical April 8, 2021 Megan M. Ritchay, A. Huggins, Alexander L. Wallace et al.

Highlights • We examined resting state connectivity in the DMN in cannabis users and controls.• Cannabis users displayed abnormal connectivity compared to healthy controls.• Abnormal connectivity in cannabis users related to poorer cognitive performance.• Abnormal brain communication may remain after ≥ 3 weeks of cannabis abstinence.

Detrimental effects of adolescent escalating low-dose Δ9 -tetrahydrocannabinol leads to a specific bio-behavioural profile in adult male rats.

British Journal of Pharmacology April 2021 Nafsika Poulia, Foteini Delis, Charalampos Brakatselos et al.

Adolescent cannabis use is associated with adult psychopathology. When Δ9 -tetrahydrocannabinol (THC), mainly in high doses, is administered to adolescence rats there are also long lasting effects in adults. This study aims to determine the specific adult bio-behavioural profile after adolescent low-dose THC, which better mirrors adolescent recreational cannabis use. Adolescent male...

DOI: 10.1111/bph.15394 (opens in new tab) Full text (opens in new tab) Neurogenesis Adolescent Biochemical pharmacology Cannabinoid +3

“I have no disease and weed just relaxes me!”: The therapeutic challenge in young patients with psychosis and cannabis abuse

European Psychiatry April 1, 2021 P. Mota

Introduction Substance use disorders (SUDs) are estimated to affect around 30 million people worldwide, and are characterized by repeated use of a substance that leads to clinically significant impairment or suffering, making it a serious health problem, with high associated costs. Objectives Understand and evaluate the impact of cannabis use on adherence to treatment in young patients with...

Are we any closer to identifying a causal relationship between cannabis and psychosis?

Current Opinion in Psychology April 1, 2021 Ian Hamilton, Harry Sumnall

This review provides the reader with an update on developments in research relating to cannabis psychosis. For over four decades researchers and clinicians have focused on the relationship between exposure to cannabis and the emergence of psychotic symptoms. This has proved to be a complicated topic to investigate but research has provided some valuable insights as to the nature of this...

Cannabis-induced oceanic boundlessness

Journal of Psychopharmacology March 28, 2021 Mitch Earleywine, Luna F. Ueno, Maha N. Mian et al. 36 citations

Background: Despite tetrahydrocannabinol (THC)’s reputation for creating dramatic effects at high doses, empirical work rarely addresses cannabis’s impact on subjective responses common to the tryptamine psychedelics. We focused on these effects because they have preceded and covaried with the therapeutic impact of psilocybin in previous work. Aims: The current study examined if self-reported...

The Impact of Cannabis Abuse on Psychotic Symptoms and Their Severity among Cannabis Associated Psychosis Subjects: An Indian Experience

Psychocentrum Review March 25, 2021 Ramchandra Lamba, Sona Budaniya, Rajendera Kumar Acharya et al.

Use of cannabis for recreational, religious and cultures has been prevalent since ancient times. It is one of the commonest used illicit substance. While not all cannabis users develop psychiatric problems, heavy cannabis use may increase the risk of cognitive abnormalities, psychotic illness and mood disorders. This research aimed to evaluate severity of various psychotic symptoms in relation...

DOI: 10.26539/pcr.31577 (opens in new tab) Psychosis Mood Cannabis dependence Schizophrenia object-oriented programming +4

Acute Pharmacological Effects and Oral Fluid Biomarkers of the Synthetic Cannabinoid UR-144 and THC in Recreational Users

Biology March 24, 2021 Nunzia La Maida, Esther Papaseit, Lucía Martínez de Soto et al. 14 citations

Synthetic cannabinoids (SCs) are one of the most frequent classes of new psychoactive substances monitored by the EU Early Warning System and World Health Organization. UR-144 is a SC with a relative low affinity for the CB1 receptor with respect to that for the CB2 receptor. As with other cannabinoid receptor agonists, it has been monitored by the EU Early Warning System since 2012 for severe...

DOI: 10.3390/biology10040257 (opens in new tab) Cannabis Heart rate Cannabinoid receptor Blood pressure +4

The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial

PLoS One March 17, 2021 Marcel O Bonn-Miller, Sue Sisley, Paula Riggs et al. 129 citations

IMPORTANCE: There is a pressing need for development of novel pharmacology for the treatment of Posttraumatic Stress Disorder (PTSD). Given increasing use of medical cannabis among US military veterans to self-treat PTSD, there is strong public interest in whether cannabis may be a safe and effective treatment for PTSD. OBJECTIVE: The aim of the present study was to collect preliminary data on...

DOI: 10.1371/journal.pone.0246990 (opens in new tab) Cannabis Placebo Randomized controlled trial Pathology +1

Schizophrenia and the Environment: Within-Person Analyses May be Required to Yield Evidence of Unconfounded and Causal Association—The Example of Cannabis and Psychosis

Schizophrenia Bulletin March 8, 2021 Jim van Os, L. Pries, M. Ten Have et al.

Abstract Hypotheses about the link between cannabis use and psychosis apply to the within-person level but have been tested mostly at the between-person level. We used a within-person design, in which a person serves as his own control, thus removing the need to consider confounding by any fixed (genetic and nongenetic) characteristic to study the prospective association between cannabis use...

Cannabis Use in Older Adults: A Perspective

Harvard Review of Psychiatry March 3, 2021 Haley V. Solomon, Aaron P. Greenstein, L. DeLisi

Abstract The prevalence of cannabis use among older adults (aged 65 and above) for both recreational and medicinal purposes has significantly increased in recent years. Information regarding the safety of cannabis in this population is important since aging is associated with metabolic changes, multiple morbidities, increases in prescription medication use, and an overall decline in...